Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Histiocytic Sarcoma · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Malignant Histiocytic and Dendritic Cell Neoplasm
Histiocytic Sarcoma

Hematologic Malignancy

Histiocytic Sarcoma

CI-CAN-00000995Explore in graph →

Hematologic4 active trials1 evidence items

NCIt: C27349
OncoTree: HDCS
OncoTree: HS
DOID: 0080915
UMLS CUI: C0334663
MeSH: D054747

Overview
Statistics
Survival
Genomics
Variants & evidence1
Drugs1
Trials6
Research
Rankings
Sources & provenance

Data completeness3 / 7 dimensions

Epidemiology (no data yet)
Survival (no data yet)
Trials (data present)
Literature (data present)
Genomics (no data yet)
Evidence (data present)
Therapies (no data yet)

Computed from entity_counters.completeness · refreshed after each connector run

Definition

What this entity is

An aggressive malignant neoplasm with a poor response to therapy, usually presenting as stage III/IV disease. It is characterized by the presence of neoplastic cells with morphologic and immunophenotypic characteristics similar to those seen in mature histiocytes.

Definition text as published by ncit-evsProvenance

Source: NCI Thesaurus (NCIt)
Dataset: NCI Thesaurus
Version: 26.08e
Retrieved: Sep 8, 2026
Layer: raw (as published)
Evidence: expert curation
License: CC BY 4.0
Run: ING-NCITEVS-20260908-000001

Open at source Curated

Data updated 22 days agoSource updated 26.08e

Taxonomy

Position in the hierarchies

Several hierarchies coexist; edges are listed per hierarchy type with their source.

Parents

ncit

Malignant Histiocytic and Dendritic Cell NeoplasmCancer Family

oncotree

Histiocytic and Dendritic Cell NeoplasmCancer Family

Children (2)

ncit

Central Nervous System Histiocytic Sarcoma
Cutaneous Histiocytic Sarcoma

Anatomy

Anatomical sites

Hematopoietic and Lymphatic SystemC35813

Record

Identity

CancerIndex ID: CI-CAN-00000995
Entity type: Hematologic Malignancy
Malignant: Yes
Solid / hematologic: Hematologic
Pediatric relevant: Not flagged
Rare cancer: Unknown (no incidence data yet)
Hierarchy depth: 4
Classification version: 26.08e
Semantic types: Neoplastic Process
Status: Active
Record updated: 2026-09-08

Coverage

Data completeness

Trials (all / active)

6 / 4

Publications (all / 5y)

1,059 / 181

Evidence items

1

Genes / variants

1 / 1

Drugs (any / approved)

1 / 0

Genomic cohorts

0

Epidemiology / survival obs.

0 / 0

Data updated 18 hours agoSource updated unknowncounters aggregate over descendants

Names

Synonyms (7)

Histiocytic Sarcomamesh_heading · MeSH
Histiocytic Dendritic Cell Sarcomasynonym · OncoTree
Histiocytic Lymphoma, Truesynonym · MeSH
Histiocytic Sarcomasynonym · OncoTree
Histiocytoses, True Malignantsynonym · MeSH
Histiocytosis, True Malignantsynonym · MeSH
SARCOMA, HISTIOCYTIC, MALIGNANTsynonym · NCIt

CancerIndex is a research and information platform. It does not diagnose and does not recommend treatment.

Key figures

At a glance

Each figure carries its unit, period and source; ranks link to "Why this rank?".

No registry-level ancestor: burden figures are published for the mutually exclusive top-level site groups only, and this entity does not descend from one. Global figures (IARC / GLOBOCAN) stay under license review and SEER awaits credentials.

Active trials4countcurrent registry status · entity + descendantsclinicaltrialsComputedrank #795 of 1,654 (World · both sexes · all ages · latest · all malignant entities)
Recruiting trials2countstatus RECRUITING · entity + descendantsclinicaltrialsComputedrank #743 of 1,277 (World · both sexes · all ages · latest · all malignant entities)
Curated evidence items1countaccepted CIViC items · entity + descendantscivicComputedrank #392 of 492 (World · both sexes · all ages · latest · all malignant entities)
Publications, last 12 months29countPubMed records · stored query · 12-month windowpubmedComputedrank #615 of 2,294 (World · both sexes · all ages · latest · all malignant entities)
Genomic cohorts0countopen GDC projects · entity + descendantsgdcComputednot in a current ranking snapshot

Data updated 18 hours agoSource updated unknownregistry figures: none · counters aggregate over descendants